Biovail Files Amended 2006 Annual Report on Form 20-F with United States Securities and Exchange Commission.TORONTO -- Biovail Corporation (NYSE NYSE See: New York Stock Exchange , TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension : BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency ) announced today that the Company has filed an amended 2006 Annual Report on Form 20-F with the United States Securities and Exchange Commission to reflect amended and restated financial information, as previously announced. A copy of Biovail's amended 2006 Annual Report on Form 20-F is available on the Company's Web site at www.biovail.com. Shareholders who wish to receive a hard copy of Biovail's completed audited financial statements free of charge should contact the Company at (905) 286-3000 and ask for Investor Relations Investor relations The process by which the corporation communicates with its investors. . Alternatively, shareholders can forward their request by EMAIL See e-mail. , including their mailing co-ordinates, to ir@biovail.com. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com. For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion